Enhancing the Mastermind User Experience Through Streamlined Workflows & Expanded Content
The team at Genomenon continues to build on its product innovations with the latest release of Mastermind, designed to further help diagnostic labs speed up workflows and quickly assess evidence for patient variants.
The Dawning of a New Age in Genomics
Genomenon’s resident Genomics visionary and Chief Scientific Officer Mark Kiel, shares his thoughts on how advances in AI, newborn screening, and collaborative research will ignite change in the coming year.
A Rare Breed: Focused on Rare Disease Therapeutics
For Rare Disease Day 2023, we celebrate 10 pharma and biotech companies that are working on cures and novel treatments for rare disease patients.
Discrepancies in Variant Classifications and How to Resolve Them
Variant classification discrepancies – where clinical laboratories and clinicians/genetic counselors disagree about the clinical meaningfulness of a variant – can impede the accurate diagnosis and subsequent treatment of patients.
ASHG and ICoNS – Event Recap and Insights from the CSO
Last week, I was in Los Angeles for ASHG. It was great to return in person after the pandemic pause to exchange ideas with industry and academic leaders in genetics. There is something irreplaceable about speaking face-to-face to make real connections and have lively discussions.
Diagnostic Perspectives from Lurie Children’s Hospital: The Value of Mastermind in Clinical CNV Interpretation
In a recent webinar, Dr. Kai Lee Yap, Director of Molecular Diagnostics at Lurie Children’s Hospital, speaks with the Genomenon team about how Mastermind is streamlining the variant interpretation process within the Department of Pathology and Laboratory Medicine.